| ||||||||||||||
|
|
|||||||||||||
,
,
*Division of Anaesthesia and
Department of Neurology, Prince of Wales Hospital;
Prince of Wales Medical Research Institute, University of New South Wales; and
§Department of Orthopaedic Surgery, Sydney Childrens Hospital, Randwick, Australia
Address correspondence and reprint requests to Professor David Burke, Prince of Wales Medical Research Institute, High St., Randwick, NSW 2031, Australia. Address e-mail to d.burke{at}unsw.edu.au
| Abstract |
|---|
|
|
|---|
Implications: Sevoflurane, thiopental, and propofol depress components of the corticospinal volley produced by transcranial electrical stimulation of motor cortex in a manner qualitatively similar to isoflurane. The findings indicate that anesthetics with primarily hypnotic actions suppress interneuronal activity in cerebral cortex.
| Introduction |
|---|
|
|
|---|
|
When added to a background anesthetic of fentanyl and nitrous oxide, isoflurane depresses the I waves of the corticospinal volley (motor evoked potential [MEP]), but has minimal effects on the shorter-latency D waves (6,7). Volatile anesthetics primarily produce unconsciousness: they may reduce analgesic requirements in a clinical situation (9), but in standard animal experiments they either have little analgesic effect or antagonize analgesia induced by nitrous oxide and narcotics (10). Propofol and thiopental are also primarily hypnotics, producing little or no analgesia (11). The present studies address the ability of primarily hypnotic anesthetics to depress I waves when added to a baseline regimen that is primarily analgesic and amnesic (12).
The question addressed by the present work was whether I waves may be used as an indication of transmission through oligo- and polysynaptic circuits in the cerebral cortex, thereby providing a model for testing anesthetic actions. If this is a valid model, one might expect different hypnotic/sedative anesthetics to have qualitatively similar effects on I wave generation. This study assesses the effects of increasing concentrations of sevoflurane and of boluses of the standard induction doses of thiopental and propofol, to determine whether I wave depression is a general effect of anesthetics that act primarily by producing unconsciousness rather than analgesia.
| Methods |
|---|
|
|
|---|
Patients were not given premedication. Induction was with thiopental, approximately 5 mg/kg, fentanyl 1.5 µg/kg, and vecuronium 0.1 mg/kg. The patients were tracheally intubated, and cannulae and probes inserted (a radial artery cannula for blood pressure monitoring, a nasopharyngeal temperature probe, and a second peripheral venous cannula, one for IV fluids and one for the administration of sodium nitroprusside). The patients were then placed in a prone position on a four-posted frame. Temperatures were maintained above 35°C with a hot air blanket over the legs, a heated humidifier in the anesthesia circuit, and a warming blanket under the support frame. A peripheral nerve stimulator was used and repeat boluses of vecuronium given so that fewer than three twitches were present after a train-of-four stimulus.
During patient positioning and the initial stages of the operation, anesthesia was supplemented with isoflurane 0.5%1% in the patients who received IV study drugs, and sevoflurane in the other patients. Nitrous oxide 60%70% was administered throughout the procedures. End-tidal carbon dioxide and volatile anesthetic concentrations were monitored using a Datex Capnomac Ultima (Datex Instrumentation, Helsinki, Finland), with the end-tidal carbon dioxide tension maintained at approximately 35 mm Hg. Mean arterial blood pressure was maintained at 5060 mm Hg using sodium nitroprusside and fentanyl.
Before either of the IV anesthetics was given, the isoflurane administration was ceased, and the end-tidal concentration allowed to decrease to <0.1% for 10 min. Whenever a low concentration of volatile anesthetic was present, midazolam 0.050.07 mg/kg and fentanyl approximately 1.5 µg/kg were given, and repeated as necessary. A baseline MEP was recorded, and the study drug was injected as a bolus. Patients therefore acted as their own control. Further recordings were made at 1-min intervals until the MEP returned to baseline. Unless otherwise specified, the data below for the IV anesthetics represent their maximal depressant effects. In four of the patients given propofol, the bolus injection of propofol was repeated after the MEP had stabilized for >10 min. Because of the slow clearance of thiopental, this drug was given only once to each patient. Three patients receiving sevoflurane became hypertensive at low concentrations, and baseline recordings were not obtained. In the other six patients, recordings were obtained between 0% and 3%. The concentration was increased by 0.5% steps to 3%. At each step, the concentration was stabilized for 10 min. In some patients, recordings were made at zero concentration more than once. The average of these was taken as the control, and all points appear in the scattergram of Figure 2.
|
|
|
|
Ten pairs of observations were obtained for each of the IV drugs, and 44 observations were taken at 0.5%, 1%, 1.5%, 2%, 2.5%, and 3% in the sevoflurane group. Mean, SD, and 95% confidence intervals were calculated and graphs drawn, using the SPSS computer package (SPSS Inc., Chicago, IL). Probabilities were calculated using the one-sample t-test (13). The significance level was taken as 5%. Each patient acted as his or her own control.
| Results |
|---|
|
|
|---|
In the control recordings for thiopental and propofol (10 for each), I waves were recorded consistently: I1, I2, and I3 in all 20 recordings, with mean amplitudes of 2.2, 3.1, and 4.0 µV respectively; I4 in 18 recordings, with mean amplitude of 3.0 µV; I5 in 12 recordings, with mean amplitude of 2.55 µV; I6 in 5 recordings and I7 in 2 recordings, both with a mean amplitude of 1.74 µV. The sum of I wave amplitudes was suppressed by the administration of thiopental or propofol in 9 of 10 recordings for each (Figs. 4 and 5).
The time to the maximal recorded depression of I-wave activity was variable in different patients, from 0.5 to 7 min and had a median value of 2 min for thiopental and 2.75 min for propofol. Nevertheless, in the four patients in whom bolus injections of propofol were studied twice, the times to maximal I wave depression were reasonably reproducible: 1 and 2.5 min, 0.5 and 1.5 min, 3 and 4 min, and 5 and 7 min. For each IV drug, the line of best fit for the pooled data on the I wave amplitude versus time graph was consistent with the expected time course of its action (Figs. 4 and 5). This suggests a drug level/effect relationship similar to that for sevoflurane (see below).
With propofol, the 10 sets of observations showed a mean decrease in I wave activity of 39% (range, 6.2% to -79.1%; Fig. 4A). The 95% confidence interval for the mean ranges from -20% to -59% (P < 0.001 by one-sample t-test). After thiopental, the maximal decrease in the I wave activity was, on average, 33% (range, 13% to -54%; Fig. 4B). The 95% confidence interval for the mean was from -20% to -46% (P < 0.001 by one-sample t-test).
After the administration of both drugs, I1, I2, and I3 underwent minimal change or even a slight increase in amplitude that was not statistically significant (Fig. 6). However, after propofol administration, the mean depression of the amplitude of I4 and I5 was 61% and 65%, respectively, and after thiopental administration, the mean depression of the amplitude of I4 and I5 was 24% and 62%, respectively. The changes in amplitude of I4 and I5 after propofol, and of I5 after thiopental, were statistically significant (all P < 0.01 by one-sample t-test).
|
Sevoflurane depressed total I wave activity in a similar manner to that previously reported for isoflurane (6), at equipotent doses (Fig. 2). The maximal concentration studied for which there was a matching control at zero concentration was 3% (1.5 minimum alveolar anesthetic concentration [MAC]). At this concentration, the amplitude of the summed I waves was depressed by approximately 70%. The relationship between the end-tidal concentration of sevoflurane and I wave activity was approximately linear, and projection of the linear regression line suggests that 100% depression would have been reached at 4% sevoflurane (2 MAC). A similar result was found when the data points of our previous study of isoflurane (6) were superimposed (Fig. 2).
During the administration of sevoflurane anesthesia, the number of I waves recorded varied between patients. The least sensitive I wave was I3, which was present in all recordings made with sevoflurane, although its amplitude was greatly attenuated by the larger sevoflurane concentrations. I1 and I2 were recordable during sevoflurane anesthesia in all but two patients. The later I waves, I4 to I6, were less frequent in control recordings without sevoflurane and, when present, proved to be very sensitive to sevoflurane. I6 was recorded in only one patient, at 0% sevoflurane. In this patient, an I5 was detectable with sevoflurane concentrations up to 3%. In all other patients, I5 was abolished by 2% sevoflurane or less.
Of the individual I waves, I3 was the largest at 0% sevoflurane and decreased rapidly in amplitude as the sevoflurane concentration was increased, so that, with 3% sevoflurane, the first three I waves were of similar size (Fig. 7).
|
| Discussion |
|---|
|
|
|---|
Our previous study showed no effect of 1% or 2% isoflurane on the mean amplitude of I1 or I2, but dramatic reduction or elimination of I3 and later waves. Likewise, the IV anesthetics had a greater effect on the later I waves, but the changes were significant at the 5% level (one-sample t-test) only for I4 and I5 after propofol and for I5 after thiopental. Some of these minor differences in the effects of each anesthetic are probably because the subjects studied were, of necessity, different for each anesthetic. We conclude that the three anesthetics we studied, and isoflurane studied previously, have qualitatively similar effects on the processes responsible for I waves.
Studies in the cat and monkey have shown that I waves produced by surface stimulation probably result from the combined excitation of many different neural elements. However, deep tangential cortico-cortical fibers in Laminae III and V play a central role in their generation (4,5,14,15). It is therefore possible that the susceptibility of I waves to thiopental, propofol, isoflurane, and sevoflurane reflects actions on cortico-cortical interneurons in Laminae III and V. This is consistent with the results of experiments on rats using depth electrodes, in which the responses of neurons in Laminae III and V of sensory cortex to a peripheral stimulus were particularly sensitive to depression by general anesthetics, including volatile anesthetics and barbiturates. In these experiments midazolam had little effect, and propofol showed less effect than the barbiturates (16). Admittedly, these data are for the sensory cortex of a rodent, but the parallel with the present findings remains.
The anesthetics studied here (and isoflurane) are primarily hypnotics and were added to a baseline anesthetic of nitrous oxide, midazolam, and fentanyl, which relies heavily on a combination of analgesia and amnesia (12,17,18). Their usage is a potentially confounding factor, but without them the studies would not have been possible. While producing acceptable clinical anesthesia, nitrous oxide, midazolam, and fentanyl do not prevent the recording of I waves (6,7; present study), and we have not noted I wave depression after bolus injections of midazolam or fentanyl. Moreover, although we recognize that anesthetics cannot be rigidly classified, there are differences between the study drugs and the drugs used for baseline anesthesia. Under experimental conditions, using the isolated forearm technique and an anesthetic of alfentanil and midazolam, patients are sometimes able to respond purposefully to verbal stimuli, demonstrating that central processing is able to occur (12). No such processing has been demonstrated with the study drugs, at more than minimal doses. Others have drawn the distinction between "general anesthetics" that have specific receptors and sites of action, including narcotics and benzodiazepines and those that do not (19). As the analgesia produced by nitrous oxide is antagonised by naloxone and
2 antagonists (20), it shares some of the properties of the former group, at least in clinical concentrations.
We conclude that thiopental, propofol, sevoflurane, and isoflurane depress interneurons in Laminae III and V of the motor cortex, thus attenuating I waves produced by transcranial electrical stimulation. This does not imply that only cortical interneurons in these laminae are affected by general anesthetics. However, if consciousness depends on functioning interneuronal circuits, this I wave model may provide insights into anesthetic actions on processes related to consciousness.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
2 adrenergic receptors in the rat. Anesthesiology 1996;85:84652.[Web of Science][Medline]
This article has been cited by other articles:
![]() |
P. C. Reinacher, H.-J. Priebe, W. Blumrich, J. Zentner, and K. M. Scheufler The effects of stimulation pattern and sevoflurane concentration on intraoperative motor-evoked potentials. Anesth. Analg., March 1, 2006; 102(3): 888 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nathan, F. Tabaraud, F. Lacroix, D. Moulies, X. Viviand, A. Lansade, G. Terrier, and P. Feiss Influence of propofol concentrations on multipulse transcranial motor evoked potentials Br. J. Anaesth., October 1, 2003; 91(4): 493 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Boisseau, M. Madany, P. Staccini, G. Armando, F. Martin, D. Grimaud, and M. Raucoules-Aime Comparison of the effects of sevoflurane and propofol on cortical somatosensory evoked potentials Br. J. Anaesth., June 1, 2002; 88(6): 785 - 789. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mori, X. Zhao, Y. Zuo, G. L. Aistrup, K. Nishikawa, W. Marszalec, J. Z. Yeh, and T. Narahashi Modulation of Neuronal Nicotinic Acetylcholine Receptors by Halothane in Rat Cortical Neurons Mol. Pharmacol., April 1, 2001; 59(4): 732 - 743. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|